Filing Details
- Accession Number:
- 0001140361-10-021828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-17 13:00:00
- Reporting Period:
- 2010-05-13
- Filing Date:
- 2010-05-17
- Accepted Time:
- 2010-05-17 17:47:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1308428 | Kieran Gallahue | Resmed Inc. 9001 Spectrum Center Boulevard San Diego CA 92123 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Common Stock | Acquisiton | 2010-05-13 | 10,000 | $38.50 | 13,224 | No | 4 | M | Direct | |
| Resmed Common Stock | Disposition | 2010-05-13 | 10,000 | $69.18 | 3,224 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Resmed Common Stock | ResMed Stock Options | Disposition | 2010-05-13 | 10,000 | $0.00 | 10,000 | $38.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,000 | 2007-02-03 | 2016-02-03 | No | 4 | M | Direct |
Footnotes
- Represents first date options became exercisable.
- This transaction was executed in multiple trades at prices ranging from $68.28 to $69.39. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
Billionaire Hedge Funds
